Prognosis and integrated management of COPD

E-poster session
Chairs: W. Labaki (Ann Arbor, United States of America), M. Vukoja (Sremska Kamenica, Republic of Serbia)

Do doctors really use COPD Guidelines? A short adherence to guidelines survey R. Crisan-Dabija (Iasi (Iasi), Romania), R. Arcana (Iasi (Iasi), Romania), C. Mitrofan (Iasi (Iasi), Romania), O. Rohozneanu (Iasi (Iasi), Romania), A. Cernomaz (Iasi (Iasi), Romania)
Floppy eyelid syndrome in Obstructive Sleep Apnea: Diagnosis and Post- CPAP changes M. Maria J SIlva (Leiria, Portugal), M. Vieira (Leiria, Portugal), C. Santos (Leiria, Portugal), N. Lopes (Leiria, Portugal), F. Carvalheira (Leiria, Portugal), J. Sousa (Leiria, Portugal), S. Feijó (Leiria, Portugal)
Identifying patient suitability for lung volume reduction – estimation of gas trapping from spirometry. A. Elbehairy (Alexandria, Egypt), J. Quint (London, United Kingdom), S. Jordan (London, United Kingdom), M. Polkey (London, United Kingdom), N. Hopkinson (London, United Kingdom)
Clinical problems of comorbidity from a position of COPD and carbohydrate metabolism disorders V. Kobylyansky (Moscow, Russian Federation), L. Morgunov (Moscow, Russian Federation), O. Povarova (Moscow, Russian Federation)
Chronic obstructive pulmonary disease (COPD) and myocardial ischemia (MI) comorbidity V. Calancea (Chisinau, Republic of Moldova), C. Martiniuc (Chisinau, Republic of Moldova), I. Sirbu (Chisinau, Republic of Moldova), S. Nichita (Chisinau, Republic of Moldova), E. Luca (Chisinau, Republic of Moldova), I. Cosciug (Chisinau, Republic of Moldova), N. Ghicavii (Chisinau, Republic of Moldova), N. Bodrug (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova)
Sleep quality assessment in chronic obstructive pulmonary disease S. JRAD (Ariana, Tunisia), I. Bachouch (Ariana, Tunisia), N. Belloumi (Ariana, Tunisia), R. Smaoui (Ariana, Tunisia), M. Hamdi (Ariana, Tunisia), D. Belkhir (Ariana, Tunisia), F. Chermiti (Ariana, Tunisia), S. Fenniche (Ariana, Tunisia)
Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study H. Shiba (Kamogawa, Japan), A. Shiroshita (Kamogawa, Japan), Y. Tanaka (Kamogawa, Japan), A. Nishi (Tateyama, Japan), C. Shirakawa (Amagasaki, Japan), K. Nakashima (Kamogawa, Japan), Y. Kataoka (Amagasaki, Japan)
“CHAOS THEORY” IN HEART RATE VARIABILITY TO A FUNCTIONAL TEST IN PATIENTS WITH COPD C. Goulart (São Carlos, Brazil), C. Brinques (Santa Cruz do Sul, Brazil), S. Souza (Santa Cruz do Sul, Brazil), K. Mansour (Santa Cruz do Sul, Brazil), G. Back (Santa Cruz do Sul, Brazil), D. Martins (Santa Cruz do Sul, Brazil), A. Borghi-Silva (São Carlos, Brazil), R. Trimer (Santa Cruz do Sul, Brazil), A. Da Silva (Santa Cruz do Sul, Brazil)
Defining the role of neutrophil-to-lymphocyte ratio in COPD patients B. Lazovic (Beograd, Republic of Serbia), S. Sarac (Beograd, Republic of Serbia), R. Milic (Beograd, Republic of Serbia), V. Zugic (Beograd, Republic of Serbia)
Ascending pain pathway function in COPD patients versus healthy controls. M. Granados Santiago (Granada, Spain), J. Rodríguez Torres (Granada, Spain), E. Prados Román (Granada, Spain), L. López López (Granada, Spain), M. Montes Ruiz-Cabello (Granada, Spain), M. Valenza (Granada, Spain)
Prevalence and clinical predictors of inhaler discordance in COPD: an observational study H. Harb (Beni-Suef, Egypt), N. Laz (Beni-Suef, Egypt), H. Rabea (Beni-Suef, Egypt), M. Abdelrahim (Beni-Suef, Egypt)
Very limited impact of chest CT-scan on the management of chronic cough. M. Descazeaux (Toulouse, France), D. Brouquières (Toulouse, France), A. Didier (Toulouse, France), M. Lescouzères (Toulouse, France), R. Escamilla (Toulouse, France), L. Guilleminault (Toulouse, France)
Hospital Stay and Economic Burden in Patients with Chronic Obstructive Pulmonary Disease between 2015 and 2019 F. Dong (Beijing, China), X. Ren (Beijing, China), K. Huang (Beijing, China), Y. Wang (Beijing, China), J. Jiao (Beijing, China), T. Yang (Beijing, China)
COPD and respiratory viral infections as risk factors for the development of cardiovascular events M. Zambrano Chacon (MADRID, Spain), L. Esteban-Lucía (MADRID, Spain), A. Izquierdo Pérez (MADRID, Spain), L. Nieto Roca (MADRID, Spain), A. Venegas Rosríguez (MADRID, Spain), C. García-Talavera (MADRID, Spain), A. Pello Lázaro (MADRID, Spain), Á. Aceña Navarro (MADRID, Spain), F. Villar Álvarez (MADRID, Spain)
Role of aerosolized therapy in the incidence of cardiac rythm disturbances in patients hospitalized with a COPD exacerbation F. Frassanito (Milano (MI), Italy), D. Radovanovic (Milano (MI), Italy), L. Perotto (Milano (MI), Italy), S. Vanni (Milano (MI), Italy), D. Raiteri (Milano (MI), Italy), M. Rizzi (Milano (MI), Italy), P. Santus (Milano (MI), Italy)
Role of diaphragm dysfunction and nutritional status on dyspnea pathogenesis in patients with COPD. F. de Blasio (Turin, Italy), M. Comune (Turin, Italy), A. Oliva (Turin, Italy), L. Garello (Turin, Italy), C. Bucca (Turin, Italy), R. Prota (Turin, Italy)
PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE K. Santillan Reyes (CDMX, Mexico), V. Peláez Hernández (CDMX, Mexico), L. Martínez Bautista (CDMX, Mexico), K. Rosales Castillo (CDMX, Mexico), L. Luna Rodríguez (CDMX, Mexico), A. Orea Tejeda (CDMX, Mexico), C. Pineda Sánchez (CDMX, Mexico), M. Quintero Martínez (CDMX, Mexico), N. Martínez Luna (CDMX, Mexico), M. Gómez Martínez (CDMX, Mexico)
Relationship between health-related quality of life and cognitive function in patientswith cardiorespiratory failure A. Martínez (Ciudad de México, Mexico), V. Peláez Hernández (Ciudad de México, Mexico), K. Santillán Reyes (Ciudad de México, Mexico), A. Orea Tejeda (Ciudad de México, Mexico), K. Rosales Castillo (Ciudad de México, Mexico), G. Luna Rodríguez (Ciudad de México, Mexico), R. Sánchez Santillán (Ciudad de México, Mexico), V. Martínez Vázquez (Ciudad de México, Mexico), Ó. Martínez Reyna (Ciudad de México, Mexico), M. Gómez Martínez (Ciudad de México, Mexico)
Evaluation of pain pressure threshold in patients with moderate to severe symptomatic COPD and healthy controls M. Granados Santiago (Granada, Spain), J. Rodríguez Torres (Granada, Spain), E. Prados Román (Granada, Spain), L. López López (Granada, Spain), M. Montes Ruiz-Cabello (Granada, Spain), M. Valenza (Granada, Spain)